JB062 is a nonmuscle myosin inhibitor with IC50 values of 1.6, 5.4, and >100 µM for Skeletal muscle myosin, Cardiac muscle myosin, and Smooth muscle myosin II, respectively. JB062 has cytotoxic to human cancer cells but not normal cells. JB062 can be used in research of muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy[1].
Molecular Weight:
323.34
CAS Number:
[2417988-00-0]
Formula:
C19H17NO4
Target:
Myosin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
